标题
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
作者
关键词
-
出版物
Orphanet Journal of Rare Diseases
Volume 18, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-01
DOI
10.1186/s13023-023-02956-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A systematic review of moral reasons on orphan drug reimbursement
- (2021) Bettina M. Zimmermann et al. Orphanet Journal of Rare Diseases
- Managing access to advanced therapy medicinal products: Challenges for NHS Wales
- (2020) Andrew R. Champion et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- From blockbuster to “nichebuster”: how a flawed legislation helped create a new profit model for the drug industry
- (2020) Daan Marselis et al. BMJ-British Medical Journal
- Comparing access to orphan medicinal products in Europe
- (2019) Bernarda Zamora et al. Orphanet Journal of Rare Diseases
- Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries
- (2019) Ewa Stawowczyk et al. Frontiers in Pharmacology
- An analysis of orphan medicine expenditure in Europe: is it sustainable?
- (2019) Jorge Mestre-Ferrandiz et al. Orphanet Journal of Rare Diseases
- New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes
- (2018) Alice Varnava et al. PHARMACOECONOMICS
- Patient Access to Medicines for Rare Diseases in European Countries
- (2018) Andreja Detiček et al. VALUE IN HEALTH
- Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods
- (2018) Siobhan M. Bourke et al. VALUE IN HEALTH
- Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
- (2018) Caridad Pontes et al. Orphanet Journal of Rare Diseases
- Profitability and Market Value of Orphan Drug Companies: A Retrospective, Propensity-Matched Case-Control Study
- (2016) Dyfrig A. Hughes et al. PLoS One
- Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries
- (2015) Todd Gammie et al. PLoS One
- Estimating the budget impact of orphan drugs in Sweden and France 2013–2020
- (2014) Adam Hutchings et al. Orphanet Journal of Rare Diseases
- Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
- (2012) Wills Hughes-Wilson et al. Orphanet Journal of Rare Diseases
- What Is Wrong with Orphan Drug Policies?
- (2012) André Côté et al. VALUE IN HEALTH
- What Is Wrong with Orphan Drug Policies? Suggestions for Ways Forward
- (2012) Panos Kanavos et al. VALUE IN HEALTH
- Estimating the budget impact of orphan medicines in Europe: 2010 - 2020
- (2011) Carina Schey et al. Orphanet Journal of Rare Diseases
- Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe
- (2010) Alain Denis et al. Applied Health Economics and Health Policy
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More